Technological Advances, Biologic Rationales, and the Associated Success of Chemotherapy With Hyperthermia in Improved Outcomes in Patients With Sarcoma

JAMA Oncol. 2018 Apr 1;4(4):493-494. doi: 10.1001/jamaoncol.2017.4941.

Authors

Mark W Dewhirst¹, David Kirsch²

Affiliations

¹ Radiation Oncology, Biomedical Engineering, Basic Science, Duke Cancer Institute, Duke University School of Medicine, Pratt School of Engineering, Durham, North Carolina.
² Radiation Oncology, Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina.

PMID: 29450459
DOI: 10.1001/jamaoncol.2017.4941

No abstract available

Publication types

Comment

MeSH terms

Biological Products*
Humans
Hyperthermia, Induced*
Neoadjuvant Therapy
Sarcoma*

Substances

Biological Products